Voss, Martin H
Chen, David
Marker, Mahtab
Hakimi, A Ari
Lee, Chung-Han
Hsieh, James J
Knox, Jennifer J
Voi, Maurizio
Motzer, Robert J
Article History
Received: 22 December 2015
Revised: 22 December 2015
Accepted: 5 January 2016
First Online: 23 February 2016
Competing interests
: MH Voss received research grants from BMS and Pfizer, advisory compensation from Novartis, Bayer, Calithera, Natera and Glaxo Smith Kline, and honoraria fees from Novartis. D Chen is an employee and stockholder of Novartis Pharmaceuticals Corp. M Marker is an employee and stockholder of Novartis Pharmaceuticals Corporation. JJ Hsieh has received research grants and advisory fees from Novartis. M Voi is an employee of Novartis Pharmaceuticals Corporation and a stockholder with Novartis, Pfizer and Bristol-Myers Squibb. RJ Motzer received research grants from Novartis, Pfizer, BMS, GlaxoSmithKline and Genentech and advisory compensation from Novartis and Pfizer. The other authors declare no conflict of interest.